The Journal of Organic Chemistry
Article
(br, 1H); 13C{1H} NMR (125 MHz, CDCl3): δ 11.1, 14.5, 18.9, 20.9,
24.3, 40.5, 59.3, 59.5, 104.8, 108.2, 116.3, 124.0, 132.1, 157.6, 165.4,
182.1; HRMS (ESI-TOF) m/z: [M + H]+ calcd for C16H23N2O2,
275.1754; found, 275.1759.
4.1.10. 8-Carboethoxy-2-ethyl-1,3-dimethyldipyrromethane (12-
DPM). mp 102−104 °C; 1H NMR (500 MHz, CDCl3): δ 1.07 (t, J =
7.5 Hz, 3H), 1.33 (t, J = 7.1 Hz, 3H), 1.97 (s, 3H), 2.10 (s, 3H), 2.37
(q, J = 7.5 Hz, 2H), 3.84 (s, 2H), 4.27 (q, J = 7.1 Hz, 2H), 6.42 (s,
1H), 7.28 (br, 2H), 8.20 (br, 1H); 13C{1H} NMR (125 MHz,
CDCl3): δ 9.0, 10.9, 14.5, 15.7, 17.7, 24.2, 59.7, 107.0, 114.2, 116.7,
120.8, 120.9, 121.9, 122.8, 130.9, 165.1; HRMS (ESI-TOF) m/z: [M
+ H]+ calcd for C16H23N2O2, 275.1754; found, 275.1744.
4.1.11. (2S,3S)-8-Carboethoxy-2-ethyl-1-formyl-3-methyl-2,3-di-
hydrodipyrrin (13). Following a general procedure,18 SeO2 (1.33 g,
12.0 mmol) was added in one portion to a solution of compound 12
(1.10 g, 4.00 mmol) in distilled 1,4-dioxane (120 mL) in the presence
of added deionized water (200 μL). The reaction mixture was stirred
at room temperature for 15 min. Upon completion, ethyl acetate (150
mL) and saturated aqueous NaHCO3 (150 mL) were added. The
organic layer was washed with water, dried (Na2SO4), concentrated,
and chromatographed [deactivated silica prepared by pretreating with
Et3N in hexanes and then removing the solvent under reduced
pressure, hexanes/ethyl acetate (2:1), 4.5 cm × 30 cm, Rf 0.47 in
hexanes/ethyl acetate (2:1)] to give a yellow paste (247 mg, 21%):
1H NMR (500 MHz, CDCl3): δ 0.90 (t, J = 7.4 Hz, 3H), 1.21 (d, J =
7.0 Hz, 3H), 1.35 (t, J = 7.1 Hz, 3H), 1.40−1.51 (m, 1H), 1.84−1.92
(m, 1H), 2.72−2.78 (m, 2H), 4.29 (q, J = 7.1 Hz, 2H), 6.21 (s, 1H),
6.69 (s, 1H), 7.54 (dd, J = 3.1 and 1.5 Hz, 1H), 9.98 (s, 1H), 10.84
(br, 1H); 13C{1H} NMR (125 MHz, CDCl3): δ 11.0, 14.5, 21.5, 24.5,
41.2, 53.8, 59.8, 112.8, 114.9, 117.4, 126.5, 131.3, 157.2, 164.7, 173.9,
190.1; HRMS (ESI-TOF) m/z: [M + H]+ calcd for C16H21N2O3,
289.1547; found, 289.1543.
4.1.12. 2-Carbomethoxy-3-[(2S,3S)-8-carboethoxy-2-ethyl-1-
formyl-3-methyl-2,3-dihydrodipyrrin-1-yl]-1-[1-(1,1-dimethoxy-
methyl)-3,3-dimethyl-2,3-dihydrodipyrrin-8-yl]prop-2-en-1-one
(14). Following a literature procedure7 with modification, samples of
13 (38.0 mg, 132 μmol), II (50.0 mg, 143 μmol), and dried molecular
sieves powder (3 Å, 45 mg) were added to a solution of piperidine/
acetic acid in acetonitrile (15 mM/15 mM, 3.50 mL, 52.8 μmol/52.8
μmol). The reaction mixture was stirred at room temperature for 20
h, whereupon an additional amount of II (9.2 mg, 26 μmol) was
added. Then, the resulting reaction mixture was stirred at room
temperature for another 20 h, followed by filtration on a Celite pad.
The filtrate was concentrated and purified by preparative TLC [20 cm
× 20 cm, 1000 μm thickness, silica, hexanes/ethyl acetate (1:1)] to
afford two orange bands, which were characterized as two isomeric
forms of the title compound. Band 2 was subsequently found by
single-crystal X-ray crystallography to be the E isomer (see the
Band 1, implied to be the Z isomer (Rf 0.55 in hexanes/ethyl
acetate (1:1), 2.3 mg, 3%): 1H NMR (500 MHz, CDCl3): δ 0.94 (t, J
= 7.4 Hz, 3H), 1.21−1.23 (m, 9H), 1.34 (t, J = 7.1 Hz, 3H), 1.41−
1.50 (m, 1H), 1.72−1.80 (m, 1H), 2.54−2.57 (m, 1H), 2.66 (s, 2H),
2.68−2.71 (m, 1H), 3.46 (s, 6H), 3.78 (s, 3H), 4.28 (q, J = 7.1 Hz,
2H), 5.04 (s, 1H), 5.86 (s, 1H), 5.99 (s, 1H), 6.57 (s, 1H), 6.59 (s,
1H), 7.11 (s, 1H), 7.52 (dd, J = 3.1 and 1.6 Hz, 1H), 7.57 (dd, J = 3.1
and 1.5 Hz, 1H), 10.79 (br, 1H), 11.26 (br, 1H); 13C{1H} NMR (125
MHz, CDCl3): δ 10.9, 14.5, 21.2, 25.0, 28.9, 40.2, 40.7, 48.4, 52.7,
54.5, 57.8, 59.6, 102.3, 106.2, 109.1, 110.2, 110.7, 116.6, 124.1, 125.9,
126.5, 130.0, 131.5, 132.7, 140.0, 157.2, 162.3, 165.0, 168.6, 172.8,
176.3, 183.5; HRMS (ESI-TOF) m/z: [M + H]+ calcd for
C34H43N4O7, 619.3126; found, 619.3123.
(125 MHz, CDCl3): δ 11.0, 14.5, 21.1, 25.1, 28.92, 28.94, 40.2, 40.6,
48.4, 52.9, 54.57, 54.58, 58.0, 59.5, 102.4, 106.3, 108.0, 110.5, 110.8,
116.2, 125.0, 126.2, 126.4, 131.4, 131.5, 133.0, 138.8, 157.1, 162.4,
165.0, 165.1, 171.9, 176.4, 188.9; HRMS (ESI-TOF) m/z [M + H]+
calcd for C34H43N4O7 619.3126; found, 619.3119.
4.1.13. (17S,18S)-3-Carboethoxy-132-carbomethoxy-17-ethyl-
8,8,18-trimethyl-131-oxo-bacteriophorbine (BC-1). Following a
literature procedure7 with modification, a sample of Yb(OTf)3 (241
mg, 388 μmol) was added to a solution of 14-E (24.0 mg, 38.8 μmol)
in acetonitrile (200 mL) in a glovebox. The reaction mixture was then
stirred at 80 °C in a sand bath for 20 h under the argon atmosphere
inside the glovebox. Then, the reaction mixture was allowed to cool to
room temperature, withdrawn from the glovebox, and filtered through
a Celite pad. The filtrate was concentrated and purified by preparative
TLC [20 cm × 20 cm, 1000 μm thickness, silica, hexanes/ethyl
acetate (3:1)] to yield a purple solid comprising two epimeric forms
in 7:1 ratio (11.5 mg, 53%). The major product determined by
NOESY spectroscopy possesses a trans−trans configuration with
1
respect to the three stereocenters in the molecule: H NMR (500
MHz, CDCl3): δ −0.67 (br, 1H), 0.66 (br, 1H), 1.00 (t, J = 7.4 Hz,
3H), 1.66 (t, J = 7.1 Hz, 3H), 1.73 (d, J = 7.4 Hz, 3H), 1.86 (s, 3H),
1.90 (s, 3H), 1.95−2.04 (m, 1H), 2.25−2.33 (m, 1H), 3.85 (s, 3H),
3.89−3.92 (m, 1H), 4.23−4.33 (m, 3H), 4.68−4.77 (m, 2H), 6.09 (s,
1H), 8.40 (s, 1H), 8.44 (s, 1H), 8.50 (s, 1H), 9.15 (d, J = 1.9 Hz,
1H), 9.49 (s, 1H); 13C{1H} NMR (125 MHz, CDCl3): δ 10.8, 14.7,
22.9, 27.6, 31.05, 31.12, 44.5, 49.5, 52.97, 53.00, 53.3, 61.5, 64.3, 98.9,
100.2, 100.6, 108.4, 109.2, 126.6, 129.8, 131.2, 137.7, 137.8, 141.0,
149.6, 159.5, 164.7, 165.2, 169.6, 171.2, 171.4, 188.9; HRMS (ESI-
TOF) m/z: [M + H]+ calcd for C32H35N4O5, 555.2602; found,
555.2591. λabs = 749 nm, λem = 753 nm, Φf = 0.17 (λex = 536 nm), in
toluene.
4.1.14. 3-Carboethoxy-132-carbomethoxy-17-ethyl-8,8,18-tri-
methyl-131-oxophorbine (C-1). A solution of bacteriochlorin BC-1
(4.0 mg, 7.2 μmol) and DDQ (3.27 mg, 14.4 μmol) in toluene (7.2
mL) was stirred at room temperature for 17 h in a glovebox filled with
argon. The reaction mixture was then quenched by the addition of
saturated aqueous NaHCO3 (10 mL). The organic phase was
collected. The aqueous phase was extracted with Et2O (3 × 10 mL).
The combined organic extract was dried (Na2SO4) and concentrated
to give a crude brown solid, which was then chromatographed in a
Pasteur pipette (silica, CH2Cl2) to yield a greenish deposit (1.4 mg,
35%): 1H NMR (500 MHz, CDCl3): δ 1.53 (t, J = 7.6 Hz, 3H), 1.70
(t, J = 7.1 Hz, 3H), 1.98 (s, 3H), 2.03 (s, 3H), 3.22 (s, 3H), 3.56 (ddt,
J = 18.5, 14.9, and 7.5 Hz, 2H), 3.79 (s, 3H), 4.54 (s, 2H), 4.78 (q, J =
7.2 Hz, 2H), 6.64 (s, 1H), 8.77 (s, 1H), 8.87 (s, 1H), 9.43 (d, J = 3.2
Hz, 1H), 9.58 (d, J = 4.1 Hz, 1H), 9.83 (s, 1H), two exchangeable
protons bound to nitrogen atoms were not unambiguously
determined; 13C{1H} NMR (125 MHz, CDCl3): 11.3, 14.8, 16.3,
20.2, 31.1, 31.3, 45.4, 52.7, 53.4, 61.5, 66.2, 97.5, 98.5, 104.2, 115.0,
143.5, 165.0, 169.6, 188.9, signals for 2 methine carbons and 11
quaternary carbons in the tetrapyrrole macrocycle were not observed;
HRMS (ESI-TOF) m/z: [M + H]+ calcd for C32H33N4O5, 553.2446;
found, 553.2435. λabs = 692 nm, λem = 695 nm, Φf = 0.41 (λex = 553
nm), in toluene.
4.2. Crystallization Protocol. Enone 14-E (20 mg) was dissolved
in acetonitrile (1 mL) and then divided equally among six 500 μL
glass insert tubes. Each insert tube was placed in a 5 mL vial
containing 1 mL of one of the following solvents: pentane, hexane,
heptane, diethyl ether, toluene, or benzene (Figure S6). The vials
were allowed to stand at room temperature for vapor diffusion. The
sample in acetonitrile/diethyl ether yielded the crystalline sample
used for X-ray crystallography analysis.
Band 2, E-isomer (Rf 0.48 in hexanes/ethyl acetate (1:1), 57.3 mg,
70%): mp 155−157 °C; 1H NMR (500 MHz, CDCl3): δ 0.92 (t, J =
7.4 Hz, 3H), 1.12 (d, J = 7.1 Hz, 3H), 1.20 (d, J = 2.8 Hz, 6H), 1.33
(t, J = 7.1 Hz, 3H), 1.39−1.47 (m, 1H), 1.74−1.81 (m, 1H), 2.47−
2.50 (m, 1H), 2.57−2.58 (m, 1H), 2.62 (s, 2H), 3.42 (d, J = 1.6 Hz,
6H), 3.78 (s, 3H), 4.26 (q, J = 7.1 Hz, 2H), 4.99 (s, 1H), 5.83 (s,
1H), 5.85 (s, 1H), 6.46 (s, 1H), 6.51 (s, 1H), 7.37 (s, 1H), 7.43 (s,
1H), 7.45 (s, 1H), 10.36 (br, 1H), 11.20 (br, 1H); 13C{1H} NMR
4.3. Molar Absorption Coefficient of BC-1. A stock solution of
1.30 mM BC-1 (7.20 mg, 13.0 μmol) in HPLC-grade toluene (10
mL) was serially diluted to form six solutions with concentrations
spanning a range from 0.13 to 6.5 μM. The absorption spectrum of
each solution was recorded. The graph of the absorbance at λ = 749
nm versus concentration was plotted, and the molar coefficient was
determined to be 72,100 M−1 cm−1 from the slope of the graph
L
J. Org. Chem. XXXX, XXX, XXX−XXX